It is entirely possible that the first effective SARS-CoV-2 vaccine is developed in Australia, with an Australian firm securing patent rights to the vaccine. If that occurs, it is important to remember that a patent is not an impenetrable fortress. Patent laws already contain mechanisms to enable “special access” to patented pharmaceuticals and other technologies, including (perhaps especially) in times like this, say James Neil and Richard Hoad of Clayton Utz.
CBA won’t hand over docs to class action without AUSTRAC’s blessing
Allianz hit with class action over ‘junk’ car insurance
Court asked to delay border closure hearing while WA expert helps Victoria fight COVID-19 outbreak
Virgin administrators’ legal woes continue as bondholders try to uncover confidential Bain deal
Queensland Nickel liquidators appeal $100M loss in case against Clive Palmer
White & Case nabs former Lendlease GC for disputes team in Sydney
Special purpose liquidators appointed by judge to investigate claims against Phoenix directors
LG loses challenge to Samsung QLED trade mark
ACCC appeals ruling that unconscionable conduct requires victims to have special disadvantage
The ACCC is challenging a ruling that dismissed the watchdog’s claim that property investment company Quantum Housing Group engaged in unconscionable conduct in misleading investors in the National Rental Affordability Scheme, saying the legal test for finding unconsionability under the consumer law needed clarifying.